Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Invested Capital (2016 - 2025)

Marimed has reported Invested Capital over the past 15 years, most recently at $54.1 million for Q4 2025.

  • Quarterly Invested Capital fell 13.5% to $54.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $54.1 million through Dec 2025, down 13.5% year-over-year, with the annual reading at $54.1 million for FY2025, 13.5% down from the prior year.
  • Invested Capital was $54.1 million for Q4 2025 at Marimed, down from $58.7 million in the prior quarter.
  • Over five years, Invested Capital peaked at $113.0 million in Q2 2023 and troughed at $14.8 million in Q1 2021.
  • The 5-year median for Invested Capital is $60.2 million (2022), against an average of $61.1 million.
  • Year-over-year, Invested Capital soared 20139.53% in 2021 and then plummeted 36.69% in 2024.
  • A 5-year view of Invested Capital shows it stood at $36.3 million in 2021, then soared by 64.57% to $59.8 million in 2022, then grew by 20.76% to $72.2 million in 2023, then dropped by 13.49% to $62.5 million in 2024, then dropped by 13.5% to $54.1 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Invested Capital are $54.1 million (Q4 2025), $58.7 million (Q3 2025), and $60.6 million (Q2 2025).